Rezpegaldesleukin, a Regulatory T-Cell Selective IL-2 Conjugate: Lessons Learned From Preclinical Design to Clinical Evaluation in Inflammatory Skin Diseases Including Atopic Dermatitis
Time: 11:45 am
day: Day Two
Details:
• Use of the appropriate design elements and experimental models for generation and preclinical evaluation
• Using clinical development approaches to address target engagement and assess PK/PD principles
• Using clinical studies to identify the correlation between the MOA and the indication
